Latest News

BTD Regimen May Be Viable Salvage Option for Multiple Myeloma

BTD Regimen May Be Viable Salvage Option for Multiple Myeloma

Bendamustine plus thalidomide and dexamethasone may be a viable salvage option for the treatment of double-relapsed/refractory multiple myeloma.

Adjusting Starting Dose of Lenalidomide for Renal Function May Not Compromise Efficacy

Adjusting Starting Dose of Lenalidomide for Renal Function May Not Compromise Efficacy

Adjusting the starting dose of lenalidomide according to renal function did not compromise the efficacy or safety of lenalidomide.

Early Initiation of Palliative Care Improves 1-Year Survival

Early Initiation of Palliative Care Improves 1-Year Survival

Early initiation of concurrent palliative oncology care improved 1-year survival compared with delayed initiation.

Biomarker Panel Shown to Be Surrogate for Survival in Prostate Cancer

Biomarker Panel Shown to Be Surrogate for Survival in Prostate Cancer

A biomarker panel was shown to be a surrogate for survival in patients with metastatic castration-resistant prostate cancer (mCRPC).

Intraperitoneal Chemotherapy Improves Survival in Ovarian Cancer

Intraperitoneal Chemotherapy Improves Survival in Ovarian Cancer

Intraperitoneal (IP) as opposed to intravenous (IV) chemotherapy is associated with better survival in patients with advanced ovarian cancer.

Patients Expect More Information About Radiation Testing

Patients Expect More Information About Radiation Testing

There is a considerable gap between patient expectations and current practices for information relating to radiation use.

In Non-Small Cell Lung Cancer, Pulmonologist Management Beneficial

In Non-Small Cell Lung Cancer, Pulmonologist Management Beneficial

For non-small-cell lung cancer (NSCLC), pulmonologist management is positively associated with rates of stage-specific treatment.

Nivolumab May Be Safe, Effective for Previously Treated Kidney Cancer

Nivolumab May Be Safe, Effective for Previously Treated Kidney Cancer

Nivolumab may be safe and effective in patients with advanced treatment-refractory renal cell carcinoma (RCC).

Tumor-Directed T Cells for HER2-Positive Sarcoma

Tumor-Directed T Cells for HER2-Positive Sarcoma

HER2-specific T cells can persist for 6 weeks without evident toxicities in patients with HER2-positive sarcoma.

Stress Management After Breast Cancer Surgery Has Lasting Benefit

Stress Management After Breast Cancer Surgery Has Lasting Benefit

Cognitive-behavioral stress management (CBSM) delivered after breast cancer surgery is associated with long-term psychological benefits.

Nivolumab Safer, More Effective Than Chemo for Advanced Melanoma

Nivolumab Safer, More Effective Than Chemo for Advanced Melanoma

Nivolumab led to a greater proportion of patients with advanced melanoma achieving an objective response and with fewer adverse events.

Doxorubicin Plus Trabectedin May Be Effective for Uterine, Soft-Tissue Leiomyosarcoma

Doxorubicin Plus Trabectedin May Be Effective for Uterine, Soft-Tissue Leiomyosarcoma

Doxorubicin plus trabectedin have activity as first-line treatment for uterine leiomyosarcoma and soft-tissue leiomyosarcoma.

Addition of Ganitumab Not Effective for Metastatic Pancreatic Cancer

Addition of Ganitumab Not Effective for Metastatic Pancreatic Cancer

Addition of ganitumab to gemcitabine did not improve overall survival in unselected patients with metastatic pancreatic cancer.

Linsitinib Not Effective for Adrenocortical Carcinoma

Linsitinib Not Effective for Adrenocortical Carcinoma

Linsitinib did not improve overall survival in patients with locally advanced or metastatic adrenocortical carcinoma.

No Non-Inferiority in Discontinuing Bevacizumab in Colorectal Cancer

No Non-Inferiority in Discontinuing Bevacizumab in Colorectal Cancer

No continuation of bevacizumab after first-line chemotherapy in metastatic colorectal cancer is not non-inferior to continuation.

For Breast Cancer Surgery, Minority Women Less Involved in Decisions

For Breast Cancer Surgery, Minority Women Less Involved in Decisions

Minority patients are less actively involved in surgeon and hospital selection for breast cancer surgery.

Non-Melanoma Skin Cancer Incidence Higher in Caucasians

Non-Melanoma Skin Cancer Incidence Higher in Caucasians

The incidence of non-melanoma skin cancer (NMSC) is much higher for Caucasians than Hispanics or Asians.

Smoking, Drinking Prolong Gastrostomy Tube Use in Head and Neck Cancer

Smoking, Drinking Prolong Gastrostomy Tube Use in Head and Neck Cancer

For patients with head and neck cancer, smoking and alcohol consumption predict gastrostomy tube (GT) insertion use.

Abiraterone Acetate with Food May Reverse PSA, Small Study Suggests

Abiraterone Acetate with Food May Reverse PSA, Small Study Suggests

Abiraterone acetate administered with food may help to reverse PSA progression in metastatic castration-resistant prostate cancer (mCRPC).

High Toxicity Rate with Chemo-Radiation in Elderly Head and Neck Cancer

High Toxicity Rate with Chemo-Radiation in Elderly Head and Neck Cancer

Acute toxicity rate is high in elderly head and neck squamous cell carcinoma patients undergoing chemotherapy and radiation therapy.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs